Valuation: MiMedx Group, Inc.

Market Cap 483M 431M 397M 360M 682M 45.27B 699M 4.75B 1.89B 24.24B 1.81B 1.77B 76.34B P/E 2026 *
-12.7x
P/E 2027 * 331x
Enterprise Value 483M 431M 397M 360M 682M 45.27B 699M 4.75B 1.89B 24.24B 1.81B 1.77B 76.34B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.65x
Free-Float
95.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.30%
1 week+1.22%
Current month-14.43%
1 month-28.91%
3 months-22.25%
6 months-6.74%
Current year-50.96%
1 week 3.05
Extreme 3.05
3.44
1 month 3.05
Extreme 3.05
4.88
Current year 3.02
Extreme 3.025
6.79
1 year 3.02
Extreme 3.025
7.77
3 years 3.02
Extreme 3.025
10.14
5 years 2.43
Extreme 2.43
10.14
10 years 0.95
Extreme 0.95
18.25
Manager TitleAgeSince
Chief Executive Officer 63 2023-01-26
Director of Finance/CFO 60 2023-07-04
Chief Tech/Sci/R&D Officer - 2021-05-31
Director TitleAgeSince
Director/Board Member 73 2019-06-18
Chairman 73 2019-06-18
Director/Board Member 63 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
7/2/26 Tax

Chief Financial Officer

-12,749 0.0086%
3/13/26 Tax

Executive/Senior Manager

6,762 0.0046%
3/13/26 Tax

Chief Administrative Officer

20,245 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+1.22%-56.94%-41.75% 483M
+2.24%+5.83%+58.47%+65.65% 66.7B
+4.66%+5.77%+16.93%+82.87% 56.88B
-0.60%+2.36%+24.32%+97.19% 56.53B
+2.55%+15.52%+26.77%+120.17% 46.49B
+2.58%+7.89%+30.88%+45.30% 44.8B
+4.09%+6.37%+219.07%+899.75% 41.59B
-0.47%+9.60%+27.53%+52.88% 35.35B
+3.80%-6.42%+98.16%+68.09% 33.29B
+1.48%+6.21%-39.51%+395.73% 25.1B
Average +2.11%+1.49%+40.57%+178.59% 40.72B
Weighted average by Cap. +2.36%+3.94%+52.06%+180.91%

Financials

2026 *2027 *
Net sales 257M 229M 211M 191M 363M 24.05B 372M 2.52B 1B 12.88B 963M 943M 40.56B 292M 261M 240M 218M 413M 27.38B 423M 2.87B 1.14B 14.66B 1.1B 1.07B 46.16B
Net income -38.95M -34.77M -31.99M -29.04M -55.03M -3.65B -56.39M -383M -153M -1.95B -146M -143M -6.16B 2.05M 1.83M 1.68M 1.53M 2.9M 192M 2.97M 20.14M 8.03M 103M 7.69M 7.53M 324M
Net Debt - -
Projected Income Statement - Annual - MiMedx Group, Inc.
Logo MiMedx Group, Inc.
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Employees
808
Date Price Change Volume
26-11-09 US$3.320 +0.30% 868,752
26-11-06 US$3.310 +0.91% 1,106,856
26-11-05 US$3.280 +2.50% 2,832,731
26-11-04 US$3.200 -1.54% 1,837,700
26-11-03 US$3.250 -0.91% 1,578,357
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - MiMedx Group, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.310USD
Average target price
7.000USD
Spread / Average Target
+111.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MiMedx Group, Inc.
  1. Stock Market
  2. Stocks
  3. MDXG Stock